CTBP1 and neoplasm: The first proof of this principle was provided by the discovery that 2-Keto-4-methylthiobutyrate (MTOB), an intermediate in methionine metabolism, is a selective inhibitor of CtBP activity capable of disrupting tumor growth in murine models10,18.